Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.7540
-0.0011 (-0.15%)
At close: Sep 17, 2025, 4:00 PM EDT
0.7540
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:00 PM EDT
Aethlon Medical Market Cap
Aethlon Medical has a market cap or net worth of $1.92 million as of September 17, 2025. Its market cap has decreased by -66.25% in one year.
Market Cap
1.92M
Enterprise Value
-1.13M
1-Year Change
-66.25%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since July 13, 2015, Aethlon Medical's market cap has decreased from $68.00M to $1.92M, a decrease of -97.17%. That is a compound annual growth rate of -29.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.00M | -83.33% |
| Dec 31, 2024 | 12.00M | 118.18% |
| Dec 29, 2023 | 5.50M | -12.70% |
| Dec 30, 2022 | 6.30M | -77.97% |
| Dec 31, 2021 | 28.60M | -4.35% |
| Dec 31, 2020 | 29.90M | 2,035.71% |
| Dec 31, 2019 | 1.40M | -95.27% |
| Dec 31, 2018 | 29.60M | 73.10% |
| Dec 29, 2017 | 17.10M | -47.22% |
| Dec 30, 2016 | 32.40M | -37.33% |
| Dec 31, 2015 | 51.70M | -23.97% |
| Jul 13, 2015 | 68.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |